About: Narrative review of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: updates and implications for practice

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Narrative review of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: updates and implications for practice Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Narrative review of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: updates and implications for practice
Creator	Al Mutair, Abbas Al-Habib, Sulaiman Ambani, Zainab
Source	Medline; PMC
abstract	Human coronaviruses (HCoVs) comprise six subtypes of coronavirus that are associated with a number of respiratory diseases such as common cold, pneumonia, and bronchitis. Middle East respiratory syndrome coronavirus (MERS-CoV) is one of these six HCoV subtypes. HCoVs can result in life-threatening respiratory diseases, such as pneumonia and bronchiolitis, and may cause enteric and neurologic diseases, especially in immunocompromised patients. This narrative review aimed to enrich the knowledge of health care professional regarding MERS-CoV infection epidemiology, control, and management. This review discusses MERS-CoV prevalence, clinical manifestation, modes of transmission, control measures, and management, which we identified in a search of various databases, related journals, and the published literature. It has been shown that MERS-CoV infection is likely to be transmitted among countries. Therefore, countries with a high rate of MERS-CoV infection are urged to develop and implement guidelines to minimize the spread of infection. Countries must give careful consideration to raising public awareness in regions that are affected by MERS-CoV infection and the importance of reporting any disease signs and symptoms, to receive proper care.
has issue date	2019-07-01(xsd:dateTime)
bibo:doi	10.1177/0300060519858030
bibo:pmid	31256729
has license	cc-by-nc
sha1sum (hex)	bef1a1f01d8a818aa005fae2e3b52dc369a79aab
schema:url	https://doi.org/10.1177/0300060519858030
resource representing a document's title	Narrative review of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: updates and implications for practice
has PubMed Central identifier	PMC7140187
has PubMed identifier	31256729
schema:publication	J Int Med Res
resource representing a document's body	covid:bef1a1f01d8a818aa005fae2e3b52dc369a79aab#body_text
is schema:about of	named entity 'epidemiology' named entity 'journals' named entity 'minimize' named entity 'control' named entity 'coronaviruses' named entity 'BRONCHIOLITIS' named entity 'NEUROLOGIC DISEASES' named entity 'VARIOUS' named entity 'CONSIDERATION' named entity 'DISEASE' named entity 'MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS' named entity 'BRONCHITIS' named entity 'AFFECTED' named entity 'develop' named entity 'disease' named entity 'MERS-CoV' named entity 'regions' named entity 'immunocompromised' named entity 'Therefore' named entity 'MERS-CoV' named entity 'coronavirus' named entity 'high' named entity 'number' named entity 'neurologic diseases' named entity 'infection' named entity 'pneumonia' named entity 'epidemiology' named entity 'MERS-CoV' named entity 'infection' named entity 'neurologic diseases' named entity 'Human coronaviruses' named entity 'MERS-CoV' named entity 'health care professional' named entity 'common cold' named entity 'infection' named entity 'coronavirus' named entity 'life-threatening' named entity 'MERS-CoV' named entity 'Middle East respiratory syndrome coronavirus' named entity 'respiratory diseases' named entity 'infection' named entity 'aerosol' named entity 'Tunisia' named entity 'bronchiolitis' named entity 'respiratory illness' named entity 'face shield' named entity 'Middle East' named entity 'MERS-CoV' named entity 'tested positive' named entity 'analgesics' named entity 'CoV' named entity 'viral load' named entity 'virus' named entity 'secondary infection' named entity 'airway' named entity 'antibiotics' named entity 'MERS-CoV' named entity 'MERS-CoV' named entity 'ICU' named entity 'virus' named entity 'Kuwait' named entity 'MERS-CoV' named entity 'Saudi Arabia' named entity 'airborne particles' named entity 'PPE' named entity 'intubation' named entity 'immunocompromised' named entity 'outbreak of MERS' named entity 'Coronavirus' named entity 'dromedary camels' named entity 'nausea' named entity 'SARS-CoV' named entity 'MERS-CoV' named entity 'bronchoscopy' named entity 'Middle East respiratory syndrome coronavirus' named entity 'severe acute respiratory syndrome coronavirus' named entity 'Middle East respiratory syndrome coronavirus' named entity 'MERS-CoV' named entity 'nasal swab'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software